FDA OKs HeartWare device for transplant patients

The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.

Regulators approved HeartWare's Ventricular Assist System, a battery-powered device that is implanted in the chest, where it helps the heart's lower left chamber pump blood throughout the body.

The FDA has previously approved similar devices, known as ventricular assist devices, but HeartWare's device is smaller and may be easier to implant in some patients.

FDA says the approval was based on a company study of 137 advanced implanted with the device. Study results showed rates of adverse events, including infection and stroke, were similar to those seen with older devices.

Medical device maker HeartWare International Inc. is based in Framingham, Mass.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US approves first heart pump for children

Dec 18, 2011

The US Food and Drug Administration has approved a first mechanical cardiac assist device for children that can help keep patients alive as they await a transplant.

Artificial heart implants approved in U.S.

Sep 06, 2006

The use of fully implanted artificial hearts for patients with advanced heart failure was approved for use Wednesday by the U.S. Food and Drug Administration.

Recommended for you

Scientists solve sudden cardiac death mystery

12 hours ago

(Medical Xpress)—Scientists have discovered the cause of sudden cardiac death in young children, for the first time making it possible to pinpoint a therapeutic target for future efforts in developing a ...

Physicians deactivate heart pump with catheter-based approach

14 hours ago

Donna Jackson's heart, on the verge of failing two years earlier, had made a strong recovery. By spring 2013, she no longer needed the left ventricular assist device, or LVAD, that had been implanted in her chest almost three ...

User comments